Phase IV Long-term Maintenance Study of Aripiprazole in the Treatment of Irritability Associated With Autistic Disorder

Completed · Phase 4 · Has a placebo group

Conditions studied: Irritability Associated With Autistic Disorder

In brief

The purpose of this study is to determine whether pediatric participants with irritability associated with autistic disorder who have responded to aripiprazole treatment will experience a relapse significantly later when continuing therapy with aripiprazole than will participants who receive placebo

Key facts

Study ID
NCT01227668
Run by
Bristol-Myers Squibb
People needed
215
Starts
2011-03-01
Expected to finish
2012-06-01
Last updated by the study team
2014-05-02

Who can join

Age: 6 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.